Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Danish (OMX) Healthcare Sector Analysis

UpdatedNov 08, 2025
DataAggregated Company Financials
Companies21
  • 7D-6.6%
  • 3M-5.3%
  • 1Y-54.3%
  • YTD-47.3%

Over the last 7 days, the Healthcare industry has dropped 4.1%, driven by a pullback from Novo Nordisk of 4.9%. However, the industry is down 51% over the past year. As for the next few years, earnings are expected to grow by 7.3% per annum.

Sector Valuation and Performance

Has the Danish Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sat, 08 Nov 2025DKK 1.8tDKK 451.6bDKK 134.3b17.6x13.2x3.9x
Mon, 06 Oct 2025DKK 2.2tDKK 447.3bDKK 141.7b18.3x15.5x4.9x
Wed, 03 Sep 2025DKK 2.1tDKK 447.5bDKK 141.8b23.9x14.6x4.6x
Fri, 01 Aug 2025DKK 1.8tDKK 423.9bDKK 124.7b29.2x14.8x4.4x
Sun, 29 Jun 2025DKK 2.4tDKK 423.1bDKK 124.5b30.5x19.2x5.7x
Tue, 27 May 2025DKK 2.5tDKK 424.3bDKK 125.1b25.1x20x5.9x
Thu, 24 Apr 2025DKK 2.3tDKK 409.3bDKK 121.3b21.6x18.7x5.5x
Sat, 22 Mar 2025DKK 2.8tDKK 409.5bDKK 121.3b24.7x23.4x6.9x
Mon, 17 Feb 2025DKK 3.0tDKK 409.9bDKK 121.5b26.3x24.9x7.4x
Wed, 15 Jan 2025DKK 3.2tDKK 387.5bDKK 111.3b28.9x28.6x8.2x
Fri, 13 Dec 2024DKK 4.0tDKK 387.4bDKK 111.3b30.8x36.1x10.4x
Sun, 10 Nov 2024DKK 3.9tDKK 386.3bDKK 110.7b32.7x35.1x10.1x
Tue, 08 Oct 2024DKK 4.1tDKK 372.0bDKK 107.1b36.3x38.6x11.1x
Thu, 05 Sep 2024DKK 4.6tDKK 371.9bDKK 107.2b35.3x43.2x12.4x
Sat, 03 Aug 2024DKK 4.5tDKK 355.3bDKK 106.3b36.6x42x12.6x
Mon, 01 Jul 2024DKK 5.0tDKK 355.3bDKK 106.2b35.1x47.4x14.2x
Wed, 29 May 2024DKK 4.6tDKK 355.3bDKK 106.2b37.2x43.6x13x
Fri, 26 Apr 2024DKK 4.4tDKK 341.4bDKK 99.6b32.8x44.3x12.9x
Sun, 24 Mar 2024DKK 4.6tDKK 341.2bDKK 99.6b39.7x45.7x13.4x
Tue, 20 Feb 2024DKK 4.4tDKK 340.0bDKK 98.7b34.9x44.7x13x
Thu, 18 Jan 2024DKK 3.8tDKK 320.5bDKK 90.0b33.5x42.1x11.8x
Sat, 16 Dec 2023DKK 3.5tDKK 320.5bDKK 90.0b32.9x38.7x10.9x
Mon, 13 Nov 2023DKK 3.6tDKK 319.8bDKK 89.9b31.7x39.6x11.1x
Wed, 11 Oct 2023DKK 3.4tDKK 305.5bDKK 82.2b34.2x41.7x11.2x
Fri, 08 Sep 2023DKK 3.6tDKK 305.5bDKK 82.2b36.3x43.3x11.6x
Sun, 06 Aug 2023DKK 2.9tDKK 288.2bDKK 74.9b38.5x38.6x10x
Tue, 04 Jul 2023DKK 3.0tDKK 287.1bDKK 75.5b39.7x39.3x10.3x
Thu, 01 Jun 2023DKK 3.1tDKK 287.2bDKK 75.5b41x40.6x10.7x
Sat, 29 Apr 2023DKK 3.1tDKK 272.6bDKK 69.0b44.7x45.1x11.4x
Mon, 27 Mar 2023DKK 2.9tDKK 291.2bDKK 69.0b36.7x42.1x10x
Wed, 22 Feb 2023DKK 2.8tDKK 289.4bDKK 68.9b40.5x40.8x9.7x
Fri, 20 Jan 2023DKK 2.7tDKK 276.0bDKK 66.3b38.4x41x9.8x
Sun, 18 Dec 2022DKK 2.7tDKK 276.1bDKK 66.3b37.7x40x9.6x
Tue, 15 Nov 2022DKK 2.5tDKK 276.0bDKK 66.4b36.1x37x8.9x
Price to Earnings Ratio

37x


Total Market Cap: DKK 2.5tTotal Earnings: DKK 66.4bTotal Revenue: DKK 276.0bTotal Market Cap vs Earnings and Revenue0%0%0%
Danish Healthcare Sector Price to Earnings3Y Average 35.3x202320242025
Current Industry PE
  • Investors are pessimistic on the Danish Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 13.8x which is lower than its 3-year average PE of 35.3x.
  • The 3-year average PS ratio of 9.8x is higher than the industry's current PS ratio of 4.1x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have grown 26% per year over the last three years.
  • Revenues for these companies have grown 18% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Danish Healthcare sector?

DK Market-2.80%
Healthcare-6.61%
Medical Equipment0.20%
Healthcare Services-2.12%
Healthtech-4.92%
Biotech-5.60%
Pharma-7.65%
Life Sciences-12.02%
Industry PE
  • Investors are most optimistic about the Healthcare Services industry which is trading above its 3-year average PE ratio of 24.9x.
    • Analysts are expecting annual earnings growth of 60.4%, which is higher than its past year's earnings decline of 47.6% per year.
Forecasted Growth
  • Analysts are most optimistic on the Healthtech industry, expecting annual earnings growth of 95% over the next 5 years.
  • In contrast, the Biotech industry is expected to see its earnings decline by 10% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
COLO B ColoplastDKK 603.003.0%
+DKK 4.0b		-33.9%PE37.4x
DEMANT DemantDKK 220.802.5%
+DKK 1.2b		-15.8%PE17.6x
GMAB GenmabDKK 1.85k0.5%
+DKK 608.1m		16.0%PE12.9x
EMBLA Embla Medical hfDKK 34.503.0%
+DKK 425.8m		-3.1%PE29.6x
STENO StenocareDKK 1.9226.3%
+DKK 15.3m		65.5%PS12.9x

Latest News

GUBRA
DKK 380.00
Gubra
7D
-11.5%
1Y
-19.1%
ZEAL
DKK 427.00
Zealand Pharma
7D
-16.7%
1Y
-49.6%
EMBLA
DKK 34.50
Embla Medical hf
7D
3.0%
1Y
-3.1%

Does Embla Medical hf (CPH:EMBLA) Have A Healthy Balance Sheet?

Nov 07
Does Embla Medical hf (CPH:EMBLA) Have A Healthy Balance Sheet?
BAVA
DKK 189.35
Bavarian Nordic
7D
-20.8%
1Y
-8.3%
NOVO B
DKK 291.20
Novo Nordisk
7D
-7.8%
1Y
-60.9%
DEMANT
DKK 220.80
Demant
7D
2.5%
1Y
-15.8%
AMBU B
DKK 81.75
Ambu
7D
-18.8%
1Y
-34.0%

AMBU B: Higher Profit Margins Will Drive Hospital Efficiency Improvements

Analysts have revised their fair value estimate for Ambu down from DKK 130.70 to DKK 121.41. They cite a slightly higher discount rate, even though profit margin and revenue growth projections have improved.
ALK B
DKK 201.00
ALK-Abelló
7D
-5.8%
1Y
29.0%

ALK B: Chinese Partnership And Revenue Upside Will Drive Future Opportunities

Analysts have raised their price target for ALK-Abelló from DKK 193 to DKK 196. This change is based on slightly improved revenue growth estimates and valuation adjustments.
COLO B
DKK 603.00
Coloplast
7D
3.0%
1Y
-33.9%
GMAB
DKK 1,847.50
Genmab
7D
0.5%
1Y
16.0%

GMAB: Recent Acquisition Will Drive Pipeline Expansion While Integration Risks Remain

Genmab's fair value estimate has been raised from DKK 2,012.92 to DKK 2,017.35. Analysts highlight the Merus acquisition's positive impact on the late-stage pipeline and renewed confidence in royalty revenue growth opportunities.
CHEMM
DKK 694.00
ChemoMetec
7D
-12.3%
1Y
43.3%

Earnings Tell The Story For ChemoMetec A/S (CPH:CHEMM) As Its Stock Soars 27%

Oct 31
Earnings Tell The Story For ChemoMetec A/S (CPH:CHEMM) As Its Stock Soars 27%
HLUN B
DKK 45.44
H. Lundbeck
7D
-3.7%
1Y
6.2%

Fewer Investors Than Expected Jumping On H. Lundbeck A/S (CPH:HLUN B)

Oct 28
Fewer Investors Than Expected Jumping On H. Lundbeck A/S (CPH:HLUN B)
STENO
DKK 1.92
Stenocare
7D
26.3%
1Y
65.5%